Rationale: Congestive heart failure (CHF) frequently results in remodeling and increased tone of pulmonary resistance vessels. This adaptive response, which aggravates pulmonary hypertension and thus, promotes right ventricular failure, has been attributed to lung endothelial dysfunction. Objective: We applied real-time fluorescence imaging to identify endothelial dysfunction and underlying molecular mechanisms in an experimental model of CHF induced by supracoronary aortic banding in rats. Methods and Results: Endothelial dysfunction was evident in lungs of CHF rats as impaired endothelium-dependent vasodilation and lack of endothelial NO synthesis in response to mechanical stress, acetylcholine, or histamine. Key Words: congestive heart failure Ⅲ pulmonary hypertension Ⅲ endothelial dysfunction Ⅲ Ca 2ϩ regulation Ⅲ cytoskeletal dynamics C ongestive heart failure (CHF) is a major and growing cause of morbidity and mortality in most affluent countries, with a prevalence approaching 10 per 1000 among those older than 65 years of age. 1 Approximately 60% to 80% of patients with CHF of systolic or diastolic origin develop pulmonary hypertension owing to left heart disease (previously known as pulmonary venous hypertension). 2,3 Importantly, this form of pulmonary hypertension is not solely caused by a "passive" increase in pulmonary vascular pressures, but is frequently aggravated by a concomitant "reactive" increase in pulmonary vascular resistance (PVR). Incidence and magnitude of this "reactive" component vary from 20% to 100% and from supranormal to extreme PVR values, and seem to worsen with progressive duration and severity of the underlying heart disease. 4 -7 The "reactive" PVR increase in CHF results both from an elevated tone and extensive remodeling of lung resistance vessels. 8, 9 The resulting increase in right ventricular afterload limits right ventricular output, and may ultimately cause fatal right ventricular failure. 2 The clinical relevance of this scenario is highlighted by epidemiological studies which identified reduced right ventricular ejection fraction as potent and independent predictor of mortality in CHF. 10 The results of several preclinical studies suggest that CHF may cause lung endothelial dysfunction, as indicated by an impaired endothelium-dependent relaxation of pulmonary artery segments in response to acetylcholine (ACh) in CHF rats. 11, 12 Consequently, lung endothelial dysfunction has been Original
C ongestive heart failure (CHF) is a major and growing cause of morbidity and mortality in most affluent countries, with a prevalence approaching 10 per 1000 among those older than 65 years of age. 1 Approximately 60% to 80% of patients with CHF of systolic or diastolic origin develop pulmonary hypertension owing to left heart disease (previously known as pulmonary venous hypertension). 2, 3 Importantly, this form of pulmonary hypertension is not solely caused by a "passive" increase in pulmonary vascular pressures, but is frequently aggravated by a concomitant "reactive" increase in pulmonary vascular resistance (PVR). Incidence and magnitude of this "reactive" component vary from 20% to 100% and from supranormal to extreme PVR values, and seem to worsen with progressive duration and severity of the underlying heart disease. 4 -7 The "reactive" PVR increase in CHF results both from an elevated tone and extensive remodeling of lung resistance vessels. 8, 9 The resulting increase in right ventricular afterload limits right ventricular output, and may ultimately cause fatal right ventricular failure. 2 The clinical relevance of this scenario is highlighted by epidemiological studies which identified reduced right ventricular ejection fraction as potent and independent predictor of mortality in CHF. 10 The results of several preclinical studies suggest that CHF may cause lung endothelial dysfunction, as indicated by an impaired endothelium-dependent relaxation of pulmonary artery segments in response to acetylcholine (ACh) in CHF rats. 11, 12 Consequently, lung endothelial dysfunction has been proposed to contribute critically to increased PVR and right ventricular afterload in CHF patients. 13 The cellular mechanisms underlying endothelial dysfunction in CHF are yet unclear but may present potential targets for prevention or treatment of pulmonary hypertension in CHF.
Here, we applied real-time fluorescence imaging of lung endothelial function and underlying signaling pathways in an experimental model of CHF in rats. Our findings identify a fundamental impairment of endothelial [Ca 2ϩ ] i signaling that is in part attributable to an extensive reorganization of the endothelial actin cytoskeleton as a new pathogenic factor in pulmonary hypertension and a novel mechanism of endothelial dysfunction in heart failure.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
In brief, CHF was induced in Sprague-Dawley rats by supracoronary aortic banding 9 weeks before the investigations. 8, 14 Sham-operated rats served as controls. Isolated lungs of CHF and control rats were prepared for real-time fluorescence microscopy as reported. 15, 16 NO synthesis in small pulmonary arterioles and lung venular capillaries was quantified by fluorescence imaging of the NO-sensitive dye DAF-FM as change in fluorescence intensity (F) over time relative to its individual baseline (F 0 ). Ca 2ϩ concentration in cytosol ([Ca 2ϩ ] i ) and endosomal stores of lung endothelial cells was quantified by ratiometric imaging of fura-2 and fura-2FF, respectively. 17 The endothelial F-actin cytoskeleton was visualized by Alexa 568 phalloidin staining as described. 18 Immunofluorescence staining for ␣-smooth muscle actin in lung microvessels was performed as reported. 19 Endothelium-dependent and -independent vasodilation was determined as dose-dependent reduction in pulmonary arterial pressure (⌬P PA ) in response to ACh and sodium nitroprusside (SNP), respectively, in lungs preconstricted with U4661951. 20 Pulmonary and systemic hemodynamics were measured in vivo in CHF and control rats as described, 8, 14 and the vasorelaxant effect of inhaled nitric oxide was determined as dose-dependent reduction in P PA . Western blot analyses from whole lung homogenate and fresh lung endothelial cells (FLECs) and immunohistochemical analyses were performed as outlined in the Online Data Supplement.
The experimental protocols included the following: (1) pharmacological interventions; (2) pressure elevation; (3) tuning of endothelial [Ca 2ϩ ] i ; and (4) actin depolymerization.
Pharmacological Interventions
Histamine (10
Ϫ6 mol/L), or the transient receptor potential vanilloid (TRPV)4 activator 4␣-phorbol-12,13-didecanoate (4␣PDD) (10 mol/L) was added to the perfusate. L-Arginine (250 mol/L), atropine (10 mol/L), or (ϩ)-tubocurarine (100 mol/L) was added 10 minutes before stimulation with ACh. Thapsigargin (2 mol/L), which releases Ca 2ϩ from endosomal stores, was infused in nominally Ca 2ϩ -free HEPES solution.
Pressure Elevation
Baseline recordings were obtained at left atrial pressure (P LA ) of 5 cmH 2 O, and P LA was raised to 15 cmH 2 O for 30 minutes by adjusting the height of the venous outflow. In a subset of experiments, P LA in CHF lungs was 15 cmH 2 O at baseline and raised to 25 cmH 2 O.
Tuning of Endothelial [Ca

2؉ ] i
Lungs were infused with nominally Ca 2ϩ -free HEPES solution containing 2% dextran and EGTA (0. 
Actin Depolymerization
Cytochalasin D (100 mol/L) was added to the perfusate 10 minutes before ACh, histamine, or P LA elevation. All data are presented as meansϮSEM.
Results
Cardiopulmonary Characterization
Nine weeks after aortic banding, CHF rats had a higher heart-to-body weight ratio as compared to controls reflecting an increase in cardiac weight as the body weight of CHF and control animals was similar (Table) . Cardiac hypertrophy was more pronounced in right than left ventricles, as demonstrated by an increased Fulton index. Elevated left ventricular enddiastolic pressure, increased P PA and PVR, and reduced static lung compliance in CHF rats reflect the characteristics of pulmonary hypertension owing to left heart disease, whereas Group data are from 10 control and CHF rats each except for epithelial lining fluid data, which are from 5 rats each. *PϽ0.05 vs control. Fulton's index was calculated as ratio of right ventricular weight (RV) over left ventricle (LV) plus septal (S) weight. P LVED indicates left ventricular end-diastolic pressure; P PA , pulmonary arterial pressure.
systemic arterial pressure was unaltered. A slight increase in wet-to-dry lung weight ratio indicates mild edema formation in CHF lungs, whereas overt alveolar flooding was absent, as indicated by similar volumes of epithelial lining fluid (Table) .
Lung Endothelial Dysfunction in CHF
Real-time imaging of DAF-FM in venular capillaries of the isolated lung revealed a deficient endothelial NO response to ACh stimulation in CHF rats ( Figure 1A) . Whereas ACh caused a dose-dependent increase in endothelial fluorescence in controls, CHF lungs showed no response ( Figure 1B) . A similar deficiency in endothelial NO production after stimulation with ACh was evident in small pulmonary arterioles of 25 to 50 m diameter ( Figure 1C ). In line with previous studies implicating the muscarinic M 3 receptor in the endothelium-dependent vasodilatory response to ACh, 21 NO production in control lungs was blocked by atropine but not tubocurarine ( Figure 1D ). Yet, the lack of an NO response in CHF lungs was not attributable to a downregulation of the M 3 ACh receptor, as demonstrated by equal expression in FLECs from control and CHF animals ( Figure 1E ).
Endothelial dysfunction in CHF lungs was confirmed by hemodynamic measurements in isolated perfused rat lungs demonstrating a complete lack of the endothelium-dependent vasorelaxant effect of ACh (Figure 2A ), whereas the endothelium-independent response to SNP was preserved ( Figure  2B ). To test the in vivo relevance of impaired endothelial NO production in CHF, we measured the lung hemodynamic response to inhaled NO. Consistent with the notion that the lung vascular bed is fully dilated under physiological conditions, NO inhalation did not affect P PA in control animals. Yet in CHF rats, NO inhalation caused a dose-dependent reduction in P PA , substantiating that lung vascular tone is increased in CHF and suggesting that restoration of endothelial NO production may mitigate pulmonary hypertension in CHF ( Figure 2C ).
The lack of endothelial NO production in CHF lungs was not exclusive for stimulation with ACh but was equally evident after stimulation with histamine despite unaltered expression of the histamine H1 receptor ( Figure 2D ). The endothelial NO response to nonpharmacological stimulation by mechanical stress was similarly abrogated in CHF. Whereas acute elevation of lung microvascular pressure stimulates endothelial NO production in control lungs, 16 this response was absent in lungs of CHF rats ( Figure 2E ). The lack of response was not attributable to diminished endothelial stretch, because amplitude and time response of vessel distension were similar in control and CHF lungs ( Figure 2F ). Infusion of the exogenous NO donor SNAP resulted in identical dose-dependent increases in DAF-FM fluorescence in control and CHF lungs ( Figure 2G ), effectively ruling out that insufficient dye loading or an impaired dye sensitivity may have contributed to the lack of fluorescence increase in CHF lungs.
Endothelial dysfunction was not attributable to downregulation of endothelial nitric oxide synthase (eNOS), as demonstrated by immunohistochemistry and Western blot analyses of both lung homogenates and FLECs which rather indicated an increase of eNOS expression in CHF lungs ( Figure 3A and 3B). The inducible NOS isoform (iNOS) was not detectable in lungs of control or CHF rats, with iNOS induction by intravenous lipopolysaccharide serving as positive control ( Figure 3C ). A critical lack of L-arginine as essential substrate for NO synthesis was excluded by experiments in which L-arginine addition to the perfusate failed to reconstitute NO production in response to ACh in CHF lungs ( Figure 3D ). Figure  4C ). Recently, we and others have shown that the lung endothelial [Ca 2ϩ ] i response to hydrostatic stress is mediated by activation of mechanosensitive TRPV4 channels. 17, 22 Consistent with the absence of a pressure-induced [Ca 2ϩ ] i response in CHF, pharmacological activation of TRPV4 by 4␣PDD increased endothelial [Ca 2ϩ ] i in control but not in CHF lungs ( Figure 4D ).
Lung
In agreement with the lack of an NO response to ACh, the atropine-sensitive endothelial [Ca 2ϩ ] i response to ACh was likewise absent in CHF lungs ( Figure 5A ). Similarly, the distinctive biphasic endothelial [Ca 2ϩ ] i response to stimulation with histamine was largely abrogated in CHF lungs and could not be recovered by up to 100-fold higher pharmacological doses ( Figure 5B ). Analogous to endothelial dysfunction, impaired endothelial [Ca 2ϩ ] i signaling was not restricted to lung venular capillaries, but was equally evident in small pulmonary arterioles as exemplified by the lack of a histamine response ( Figure 5C ). To test whether downregulation of endothelial Ca 2ϩ entry channels may account for the impaired Ca 2ϩ response to mechanical and pharmacological stimulation, we analyzed the expression of cation channels of the TRPV and transient receptor potential canonical (TRPC) family in lung endothelial cells. TRPV2 and TRPV4 ( Figure  5D ) were markedly downregulated in CHF as compared to control lungs, suggesting that a lower expression of these mechanosensitive cation channels may contribute to the lack of endothelial [Ca 2ϩ ] i responses to hydrostatic stress or 4␣PDD. However, TRP channels of the canonical superfamily including, TRPC1, TRPC4, and TRPC6, which have been implicated in the [Ca 2ϩ ] i response to ligands such as histamine, thrombin, or ACh, 23, 24 were not differentially expressed in CHF and control lungs ( Figure 5E ). Next, we addressed whether depletion of endosomal Ca 2ϩ stores may contribute to the impaired endothelial [Ca 2ϩ ] i response in CHF lungs. This possibility was effectively ruled out by fura-2FF imaging of endosomal Ca 2ϩ , which revealed an equivalent Ca 2ϩ release from endosomal stores after thapsigargin treatment in Ca 2ϩ -free perfused CHF and control lungs ( Figure 5F ). However, the concomitant increase in endothelial [Ca 2ϩ ] i 
Cytoskeletal Reorganization
Based on the notion that actin filaments play a fundamental role in intracellular Ca 2ϩ homeostasis 25, 26 and may regulate Ca 2ϩ influx via store-operated and TRP channels, 27 we addressed the effects of CHF on the actin cytoskeleton and its role in endothelial dysfunction. Imaging of fluorescently labeled phalloidin in control lungs showed circular F-actin filaments which were particularly pronounced at microvascular bifurcations and more prominent in small pulmonary arterioles as compared to venular capillaries ( Figure 6A and 6B) . In CHF lungs, phalloidin staining was enhanced several-fold in both small pulmonary arterioles and venular capillaries as compared to controls, and spirally arranged actin microfilaments were distributed over the entire length of microvascular segments ( Figure 6A and 6B). Phalloidin staining was specific for actin microfilaments, because fluorescence intensity was reduced by several orders of magnitude when microvessels were pretreated with cytochalasin D, which cleaves actin microfilaments, whereas degradation of elastic fibers with elastase had no effect ( Figure 6C ). Although a potential contribution of smooth muscle cells to the phalloidin signal in small pulmonary arterioles cannot be excluded because of methodological constraints, the increased phalloidin fluorescence in venular capillaries of CHF as compared to control lungs was clearly attributable to cytoskeletal reorganization in the microvascular endothelium, because the respective microvessels were devoid of ␣-smooth muscle actin ( Figure  6D ). The notion of a significant reorganization of the endothelial actin cytoskeleton in CHF was substantiated by Western blot analyses of FLECs demonstrating a Ϸ13-fold increase in ␤-actin expression in FLECs of CHF as compared to controls ( Figure 6E ).
To test whether cytoskeletal reorganization contributes to endothelial dysfunction, we pretreated CHF and control lungs with cytochalasin D. In CHF lungs, cytochalasin D restored the endothelial [Ca 2ϩ ] i increase in response to hydrostatic stress as demonstrated by representative images ( Figure 7A ) and single cell tracings ( Figure 7B ), yet did not re-establish endothelial [Ca 2ϩ ] i oscillations. Likewise, cytochalasin D restored the endothelial [Ca 2ϩ ] i increase in response to histamine in both lung venular capillaries ( Figure 7C ) and small arterioles ( Figure 7D ) of CHF lungs, but had no detectable effect on baseline [Ca 2ϩ ] i or the histamine response in control lungs.
Consistent with the notion that restoration of endothelial [Ca 2ϩ ] i signaling can reverse endothelial dysfunction in CHF, cytochalasin D partially reconstituted endothelial NO production in response to hydrostatic stress as shown in representative images ( Figure 7E ) and single cell tracings (Figure 7F) , respectively. Similarly, microfilament disruption partially restored the endothelial NO response to ACh in venular capillaries ( Figure 7G ) and small arterioles ( Figure 7H ) of CHF lungs without detectable effects on NO production in control lungs.
Discussion
Here, we show that CHF causes endothelial dysfunction in pulmonary microvessels as demonstrated by a lack of NO synthesis in response to mechanical or receptor-mediated stimulation in lung venular capillaries and small arterioles, and by the lack of an endothelium-dependent vasorelaxant response to ACh. Reduced expression or eNOS substrate deficiency, poor dye loading, insufficient stimulation attributable to reduced receptor expression or lesser mechanical stretch could be ruled out as potential underlying mechanisms. Instead, the almost complete lack of an endothelial [Ca 2ϩ ] i response to mechanical stress, ACh, or histamine and the reconstitution of endothelial NO synthesis by Ca 2ϩ ionophore treatment revealed that endothelial dysfunction was caused by impaired endothelial [Ca 2ϩ ] i signaling. Cytoskeletal reorganization in lung endothelial cells, which was evident as many-fold increases in F-actin content and ␤-actin expression, was identified to play a critical role in this scenario, because cytochalasin D largely reconstituted endothelial [Ca 2ϩ ] i signaling and NO synthesis in response to appropriate stimulation. Although underlying molecular mechanisms remain to be elucidated, our results identify regulation of [Ca 2ϩ ] i signaling and NO synthesis by cytoskeletal reorganization as a novel and clinically relevant mechanism of endothelial cell adaptation in cardiovascular disease.
Lung Endothelial Dysfunction in CHF
In systemic blood vessels of CHF patients or animal models, endothelial dysfunction contributes critically to impaired coronary and systemic perfusion with fundamental impact on morbidity and mortality. 28 In the lung, endothelial dysfunction in CHF has been proposed to induce a reactive increase in PVR, causing pulmonary hypertension and ultimately right ventricular failure. 13 Here, we used our established real-time imaging techniques to directly visualize deficient endothelial NO production in lung venular capillaries of CHF rats. 16, 29 The additional demonstration of an essentially similar dysfunction in small pulmonary arterioles constitutes to our knowledge the first reported real-time imaging of pulmonary arterial endothelial cells in the intact lung.
In normal lungs, capillary NO production in response to ACh was sensitive to atropine but not tubocurarine, suggesting a role for capacitative Ca 2ϩ influx in the NO response. 30 In capillaries and arterioles of CHF lungs, endothelial dysfunction was manifest as lack of NO production in response to ACh, histamine or mechanical stress. Likewise, endothelial dysfunction was functionally evident as lack of endotheliumdependent vasodilation in response to ACh in the presence of a preserved endothelium-independent vasorelaxation. Of note, the half-maximal effective ACh concentration (EC 50 ) for capillary NO production exceeds the EC 50 for the AChdependent reduction in P PA by almost 10-fold. Although this discrepancy may be attributable to a lesser sensitivity of lung capillaries to ACh as compared to pulmonary resistance vessels, it may equally suggest that endothelial NO production is yet submaximal when ACh-dependent vasorelaxation is complete. Our experiments rule out downregulation of eNOS or lack of eNOS substrate which have been shown to underlie endothelial dysfunction in pulmonary arterial hypertension, 31, 32 and consequently suggest that lung endothelial dysfunction in CHF may be attributable to impaired posttranslational regulation of eNOS. 23, 24 were equally expressed in CHF and control lungs. This finding is in notable contrast to data from Alvarez et al demonstrating downregulation of endothelial TRPC1, TRPC3, and TRPC4 in an aortocaval fistula model of heart failure in rats, indicating considerable differences between lung vascular adaptation in high-flow (fistula) and low-flow (aortic banding) CHF models. 34 store depletion in animal models of heart failure. 34, 35 In these studies, administration of a Ca 2ϩ ionophore increased permeability equally in control and heart failure lungs effectively ruling out endothelial Ca 2ϩ desensitization. These data are in line with the lack of endothelial [Ca 2ϩ ] i responsiveness demonstrated by real-time imaging in the present study. Our finding that the Ca 2ϩ ionophore A-23187 reconstituted NO production in CHF lungs stresses the functional relevance of this adaptation as the predominant cause of lung endothelial dysfunction in CHF and provides a mechanistic explanation for previously reported, yet so far inexplicable data that demonstrated an attenuated vasodilation of pulmonary arterial rings from CHF rats in response to ACh, although the relaxation response to A-23187 was preserved. 12 Notably, a similar impairment of endothelial Ca 2ϩ homeostasis, ie, reduced basal [Ca 2ϩ ] i and store-operated Ca 2ϩ entry, was recently reported in pulmonary endothelial cells from chronically hypoxic rats, 36 suggesting that this mechanism of endothelial dysfunction may also be relevant to noncardiogenic forms of pulmonary hypertension.
Impaired Lung Endothelial
Cytoskeletal Reorganization
We focused on adaptive changes of the endothelial actin cytoskeleton in CHF and their potential role in impaired endothelial [Ca 2ϩ ] i signaling based on: (1) the consideration that F-actin constitutes the only Ca 2ϩ binding system able to store considerable amounts of Ca 2ϩ ions at physiological [Ca 2ϩ ] i 25, 26 ; (2) the finding that a dense cortical actin layer effectively prevents Ca 2ϩ influx via storeoperated and TRPC3 channels 27 ; and (3) the fact that cytoskeletal organization and actin expression in endothelial cells adapt to chronically altered mechanical stress, eg, in simulated microgravity. 37 Endothelial actin microfilaments were most prominent at vascular bifurcations in line with their ability to provide structural support at sites of mechanical stress. 18 Surprisingly, endothelial F-actin filaments enfolded lung capillaries in circular and spiral arrangements which is in contrast to data from cultured pulmonary artery endothelial cells where microfilaments align parallel to flow. 38 Although this arrangement is reminiscent of smooth muscle cells, a contamination of the phalloidin signal could be effectively excluded by the negative immunostaining for ␣-smooth muscle actin in lung capillaries. Importantly, a spiral arrangement may be advantageous in providing both structural stability and elasticity in an organ in which microvessels continuously undergo cyclic longitudinal stretch resulting from respiratory movements.
Phalloidin imaging and Western blot analyses from FLECs revealed an abundant increase in F-actin content and ␤-actin expression in endothelial cells of CHF lungs, and microfilament disruption by cytochalasin D largely reconstituted endothelial [Ca 2ϩ ] i and NO responses. These findings demonstrate that lung endothelial cells adapt to CHF by cytoskeletal reorganization with profound implications on cell signaling and function. The molecular mechanism by which actin expression and arrangement regulate endothelial [Ca 2ϩ ] i signaling and NO synthesis remains to be elucidated, but may involve one or more of the following scenarios. First, rapid Ca 2ϩ binding by G-actin monomers and Ca 2ϩ storage by F-actin polymers 26 may act as physiological sink to buffer Ca 2ϩ influx and release in endothelial cells that express more than 10-fold higher actin levels as normal. This hypothesis is in agreement with our finding of an attenuated [Ca 2ϩ ] i response to thapsigargin in CHF despite a comparable Ca 2ϩ release from endosomal stores, and with previous data demonstrating that cytochalasin D prolongs [Ca 2ϩ ] i elevations in response to thapsigargin or Ca 2ϩ ionophores in T-cells. 39 Second, the identification of the Stim/Orai coupling machinery as molecular mechanism of store-operated Ca 2ϩ entry 40 raises the possibility that translocation of the endosomal Ca 2ϩ sensor Stim1 to or interaction with poreforming Orai proteins in the plasma membrane may be impaired by a dense cortical actin layer. Such a scenario could explain some aspects of impaired [Ca 2ϩ ] i signaling in CHF, eg, the lack of a store-operated Ca 2ϩ entry following histamine stimulation, but does not provide a mechanistic explanation for the absence of the initial histamine response or the attenuated [Ca 2ϩ ] i response to thapsigargin. For similar reasons, internalization of TRPC Ca 2ϩ channels by cytoskeletal reorganization, as recently described in neutrophils, 41 ] i oscillations in CHF lungs. The fungal metabolite cytochalasin D inhibits actin polymerization and disrupts actin microfilaments, and was therefore used in our study to provide proof-of-principle for a functional role of cytoskeletal remodeling in impaired [Ca 2ϩ ] i signaling and endothelial dysfunction in CHF. Yet, at the same time, this intervention can be considered too crude and generalized to restore all facets of the complex regulation of endothelial [Ca 2ϩ ] i signaling and may simultaneously trigger secondary responses, which in turn affect endothelial [Ca 2ϩ ] i homeostasis. Furthermore, additional, yet unidentified adaptive mechanisms can be expected to contribute to the unique lung endothelial phenotype in CHF.
In summary, we identify a fundamental impairment in endothelial [Ca 2ϩ ] i homeostasis and signaling as novel mechanism underlying lung endothelial dysfunction in CHF. The functional relevance of this defect is illustrated by our finding that inhalation of exogenous NO decreased P PA and thus mitigated pulmonary hypertension in CHF rats. This singular adaptation of endothelial cell responsiveness in CHF is primarily caused by a massive reorganization of the endothe-
